Should we close hypoxaemic patent foramen ovale and interatrial shunts on a systematic basis?
Juliard
Jean-Michel
JM
Aubry
Pierre
P
Ducrocq
Gregory
G
Lepage
Laurent
L
Brochet
Eric
E
D006328:Cardiac Catheterization / Q000009:adverse effects / Q000295:instrumentation*; D002908:Chronic Disease; D054092:Foramen Ovale, Patent / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D006344:Heart Septal Defects, Atrial / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D006439:Hemodynamics; D006801:Humans; D000860:Hypoxia / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D018579:Patient Selection; D020127:Recovery of Function; D012131:Respiratory Insufficiency / Q000150:complications; D055989:Septal Occluder Device; D013997:Time Factors; D016896:Treatment Outcome